UEMURA Hirotsugu 植村天受

… Alternative Names

Researcher Number	90213397
Other IDs
External Links
Affiliation (Current)	2020: 近畿大学, 医学部, 教授
Affiliation (based on the past Project Information) *help	2010 – 2020: 近畿大学, 医学部, 教授 2004 – 2008: 近畿大学, 医学部, 教授 2007: Kinki University, 近畿大学, 教授 2004: Kinki Univ., Dept.of Urology, Professor, 泌尿器科, 教授 2003: Nara Med.University, Dept.Urology, Professor, 医学部, 助教授 … More
Review Section/Research Field	Principal Investigator Urology / Urology / Basic Section 56030:Urology-related Except Principal Investigator Urology / Urology / Basic Section 56030:Urology-related / Experimental pathology
Keywords	Principal Investigator 腎細胞癌 / CA9 / MN / ペプチドワクチン / renal cell carcinoma / 免疫療法 / EPOR / 癌ワクチン / VEGFR / 腎細胞がん … More Except Principal Investigator 前立腺癌 / MN / CA9 / RT-PCR / 動物モデル / PTEN / Renal cell carcinoma / 腎細胞癌 / 分子標的治療 / ペプチド / バイオマーカー / Cre-LoxPシステム / 泌尿器癌 / PTEN癌抑制遺伝子 / 遺伝子治療 / 遺伝子改変マウスモデル / ノックアウトマウス / マウスモデル / 去勢抵抗性がん / マーカー / ペプチドワクチン / HLA-A3 / EZH2 / 遺伝子改変マウス / p53 / 前臨床試験 / PTENノックアウトマウス / PTEN/p53 DKO / PSAコンディショナル / MN抗原 / mAbG250 / 免疫組織化学 / G250抗原 / MAbG250 / Anti-idiotype antibody / Immunotherapy / 抗体 / antibody / プロモーター / DNAメチル化 / DNA メチル化 / プロモータ / methylation / 血中癌細胞 / renal cell carcinoma / antigen peptide / SEREX法 / Urological tumor / SEREX / Prostate cancer / PTEN tumor suppressor gene / gene therapy / 分子マーカー / 放射線療法 / ペプチド療法 / Prostate Cancer / Molecular Therapy / PTEN Tumor Suppressor Gene / Peptide / ノンコーディングRNA / バイオマーカ / PTENノックアウト / 腫瘍免疫 / トランスクリプトーム解析 / 前立腺がん / アミノ酸トランスポーター / Liquid Biopsy / 去勢抵抗性 / 腫瘍微小免疫環境 / 複合免疫療法 Less

Establishment of aminoacid transporter directed prostate cancer therapy based on the liquid biopsyOngoing
- Principal Investigator
  
  坂本信一
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Chiba University
前立腺癌における腫瘍微小免疫環境の変化に関する基礎的研究Ongoing
- Principal Investigator
  
  デベラスコマルコ
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kindai University
腎細胞癌に対するマルチペプチド癌ワクチンの開発、複合免疫療法としての有用性の検討Principal InvestigatorOngoing
- Principal Investigator
  
  植村天受
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kindai University
Noncoding RNA expression profiling in mouse PTEN-deficient prostate cancer as a potential biomarker
- Principal Investigator
  
  DE VELASCO Marco
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kindai University
Development of the HLA-A2 restricted multi-peptides vaccine for renal cell carcinoma.Principal Investigator
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Kindai University
Development of PSA-conditional PTEN/p53 double knockout mouse prostate cancer model
- Principal Investigator
  
  DE VELASCO Marco
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kindai University
Functional analysis of autophagy in PTEN/Atg7 double knockout mouse prostate cancerPrincipal Investigator
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Urology
- Research Institution
  Kinki University
Development of multi-peptide tumor vaccine for renal cell carcinomaPrincipal Investigator
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Identification of cancer-derived peptides as potential candidates for the development of anti-cancer vaccines for prostate cancer patients
- Principal Investigator
  
  MINAMI Takafumi
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Development of tailor made peptide vaccines for renal cell carcinomaPrincipal Investigator
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Pre-clinical applications using PTEN-knockout prostate cancer mouse model
- Principal Investigator
  
  DE VELASCO Marco
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Development of tailor-madepeptide vaccines for renal eell carcinomaPrincipal Investigator
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Novel molecular therapeutic strategies in prostate cancer
- Principal Investigator
  
  TANAKA Motoyoshi
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Molecular Therapy Targeting PTEN-Akt Signaling Pathway in Prostate Cancer.
- Principal Investigator
  
  TANAKA Motoyoshi
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kinki University
  Nara Medical University
Development new generation peptides derived from CA9 as tailar-made vaccines for renal cell carcinomaPrincipal Investigator
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2004 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Kinki University
Application for PTEN Gene Therapy in Prostate Cancer
- Principal Investigator
  
  TANAKA Motoyoshi
- Project Period (FY)
  2003 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Nara Medical University School of Medicine
MN/CA9 expression and VHL regulation in renal cell carcinomaPrincipal Investigator
- Principal Investigator
  
  UEMURA Hirotsugu, 趙順規
- Project Period (FY)
  2002 – 2003
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Nara Medical University
Active specific immunotherapy with MN\CA IX antigen peptide vaccines for renal cell carcinomaPrincipal Investigator
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Nara Medical University
Search for new target antigens of cancer by the SEREX method using cancer patient's serum containing antibodies
- Principal Investigator
  
  YOSHIKAWA Kazuhiro
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  AICHI MEDICAL UNIVERSITY
Clinical Significance for detection of circulating renal cancer cells in the blood by RT-PCR
- Principal Investigator
  
  HIAO Yoshihiko
- Project Period (FY)
  2000 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  Nara Medical University
Elucidation of activation mechanism of MN/CA9 in human renal cell carcinomas
- Principal Investigator
  
  CHO Masaki
- Project Period (FY)
  1999 – 2000
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Experimental pathology
- Research Institution
  NARA MEDICAL UNIVERSITY
Specific immunotherapy targeting MN/CA9 tumor-associated antigen for renal cell carcinomaPrincipal Investigator
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  1999 – 2000
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Nara Medical University
Establishment of diagnosis and therapy in renal cell carcinomas by MN/CAIX antibody
- Principal Investigator
  
  HIRAO Yoshihiko, 仲川嘉紀
- Project Period (FY)
  1998 – 1999
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  NARA MEDICAL UNIVERSITY
Molecular detection of circulating renal cell carcinoma cells by RT-PCRPrincipal Investigator
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  1997 – 1998
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Nara Medical University
A tumor-associated antigen MN/G250 in urologic malignancies ; potetial therapeutic target
- Principal Investigator
  
  HIRAO Yoshihiko, 百瀬均
- Project Period (FY)
  1996 – 1997
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  NARA MEDICAL UNIVERSITY
Tools for active specific immunotherapy with anti-idiotype antibodies in human renal cell carcinomaPrincipal Investigator
- Principal Investigator
  
  UEMURA Hirotsugu
- Project Period (FY)
  1995 – 1996
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  NARA MEDICAL UNIVERSITY

[Book] Year Book of RCC 2008. RCCに対する癌ワクチン療法のトピックス2008
- Author(s)
  植村天受
- Publisher
  メディカルレビュー社
- Data Source
  KAKENHI-PROJECT-19390419
[Book] Cancer Treatment Navigator 腎癌の分子標的治療2008
- Author(s)
  植村天受
- Publisher
  メディカルレビュー社
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] Chemopreventive effects of nanoparticle curcumin in a mouse model of Pten-deficient prostate cancer.2020
- Author(s)
  De Velasco Marco A, Kura Y, Sakai K, Hatanaka Y, Davies BR, Campbell H, Klein S, Kim Y, MacLeod AR, Sugimoto K, Yoshikawa K, Nishio K, Uemura H.
- Journal Title
  
  Hum Cell
  
  Volume: 7
- DOI
  10.1007/s13577-020-00337-7
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11165
[Journal Article] HOXA10 expression profiling in prostate cancer2019
- Author(s)
  Hatanaka Yuji、de Velasco Marco A.、Oki Takashi、Shimizu Nobutaka、Nozawa Masahiro、Yoshimura Kazuhiro、Yoshikawa Kazuhiro、Nishio Kazuto、Uemura Hirotsugu
- Journal Title
  
  The Prostate
  
  Volume: 79 Pages: 554-563
- DOI
  10.1002/pros.23761
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K11165, KAKENHI-PLANNED-17H06404
[Journal Article] Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy2019
- Author(s)
  De Velasco Marco A.、Kura Yurie、Sakai Kazuko、Hatanaka Yuji、Davies Barry R.、Campbell Hayley、Klein Stephanie、Kim Youngsoo、MacLeod A. Robert、Sugimoto Koichi、Yoshikawa Kazuhiro、Nishio Kazuto、Uemura Hirotsugu
- Journal Title
  
  JCI Insight
  
  Volume: 4
- DOI
  10.1172/jci.insight.122688
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11165
[Journal Article] Generation of PTEN-knockout (-/-) murine prostate cancer cells using the CRISPR/Cas9 system and comprehensive gene expression profiling2018
- Author(s)
  Takao Akiko、Yoshikawa Kazuhiro、Karnan Sivasundaram、Ota Akinobu、Uemura Hirotsugu、De Velasco Marco、Kura Yurie、Suzuki Susumu、Ueda Ryuzo、Nishino Tokiko、Hosokawa Yoshitaka
- Journal Title
  
  Oncology Reports
  
  Volume: 40 Pages: 2455-2466
- DOI
  10.3892/or.2018.6683
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K11165, KAKENHI-PROJECT-18K08342
[Journal Article] Hypoxia-inducing factor (HIF)-1a;-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2017
- Author(s)
  1.Minami T, Matsumura N, Sugimoto K, Shimizu N, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
- Journal Title
  
  International Immunopharmacology
  
  Volume: 44 Pages: 197-202
- DOI
  10.1016/j.intimp.2017.01.014
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05466, KAKENHI-PROJECT-17K07217
[Journal Article] Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer.2016
- Author(s)
  De Velasco MA, Kura Y, Yoshikawa K, Nishio K, Davies BR, Uemura H.
- Journal Title
  
  Oncotarget.
  
  Volume: 7 Pages: 15959-15976
- DOI
  10.18632/oncotarget.7557
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26670707, KAKENHI-PROJECT-26462433
[Journal Article] Conditional PTEN-deficient mice as a prostate cancer chemoprevention model.2015
- Author(s)
  Koike H1, Nozawa M, De Velasco MA, Kura Y, Ando N, Fukushima E, Yamamoto Y, Hatanaka Y, Yoshikawa K, Nishio K, Uemura H.
- Journal Title
  
  Asian Pac J Cancer Prev.
  
  Volume: 16 Pages: 1827-1831
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26462433
[Journal Article] New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles.2015
- Author(s)
  Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M A, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
- Journal Title
  
  Int Immunopharmacol.
  
  Volume: 26 Pages: 133-138
- DOI
  10.1016/j.intimp.2015.03.023
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-24592416, KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
[Journal Article] Identification of Programmed Death Ligand 1-derived Peptides Capable of Inducing Cancer-reactive Cytotoxic T Lymphocytes From HLA-A24+ Patients With Renal Cell Carcinoma.2015
- Author(s)
  Minami T., Minami T., Shimizu N., Yamamoto Y., De Velasco MA., Nozawa M., Yoshimura K., Harashima N., Harada M., Uemura H.
- Journal Title
  
  J Immunother.
  
  Volume: 38 (7) Pages: 285-289
- DOI
  10.1097/cji.0000000000000090
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
[Journal Article] Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer.2015
- Author(s)
  Yamamoto Y, De Velasco MA, Kura Y, Nozawa M, Hatanaka Y, Oki T, Ozeki T, Shimizu N, Minami T, Yoshimura K, Yoshikawa K, Nishio K, Uemura H.
- Journal Title
  
  J Transl Med.
  
  Volume: 13 Pages: 150-162
- DOI
  10.1186/s12967-015-0509-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26670707
[Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma.2014
- Author(s)
  Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
- Journal Title
  
  Int Immunopharmacol.
  
  Volume: 20 Pages: 59-65
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25293336
[Journal Article] Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon--mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system2014
- Author(s)
  Harashima N, Minami T, Uemura H, Harada M
- Journal Title
  
  Mol Cancer.
  
  Volume: 13 Pages: 217-217
- DOI
  10.1186/1476-4598-13-217
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-25293336, KAKENHI-PROJECT-25430150
[Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2014
- Author(s)
  Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H
- Journal Title
  
  Int Immunopharmacol.
  
  Volume: 20 Pages: 59-65
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25293336
[Journal Article] Androgen deprivation induces phenotypic plasticity and promotes resistance to molecular targeted therapy in a PTEN-deficient mouse model of prostate cancer2014
- Author(s)
  M.A. De Velasco, M. Tanaka, Y. Yamamoto, Y. Hatanaka, H. Koike, K. Nishio, K. Yoshikawa and H. Uemura
- Journal Title
  
  Carcinogenesis
  
  Volume: 35 Pages: 2142-2153
- DOI
  10.1093/carcin/bgu143
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26462433
[Journal Article] STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma2013
- Author(s)
  Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S
- Journal Title
  
  Japan Immunotherapy SNPs-Study Group for Kidney Cancer
  
  Volume: Eur Urol Pages: 745-52
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] Role of vaccine therapy for renal cell carcinoma in the era of targeted therapy.2013
- Author(s)
  Yoshimura K, Uemura H. Yoshimura K, Uemura H.
- Journal Title
  
  Int J Urol.
  
  Volume: - Pages: 1-10
- DOI
  10.1111/iju.12147
- NAID
  10031190532
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305, KAKENHI-PROJECT-25293336
[Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma.2013
- Author(s)
  Yoshimura K, Minami T, Nozawa M, Uemura H.
- Journal Title
  
  Br J Cancer.
  
  Volume: 108 Pages: 1260-1266
- DOI
  10.1038/bjc.2013.90
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305, KAKENHI-PROJECT-25293336
[Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma2013
- Author(s)
  Yoshimura K, Minami T, Nozawa M, Uemura H
- Journal Title
  
  Br J Cancer
  
  Volume: 108(6) Pages: 1260-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] STAT3 Polymorphism Can Predict the Response to Interferon-a Therapy in Patients with Metastatic Renal Cell Carcinoma.2013
- Author(s)
  Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S; Japan Immunotherapy SNPs-Study Group for Kidney Cancer.
- Journal Title
  
  European Urology
  
  Volume: 63 Pages: 745-752
- DOI
  10.1016/j.eururo.2012.09.052
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305, KAKENHI-PROJECT-24592391, KAKENHI-PROJECT-24659718
[Journal Article] Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway.2012
- Author(s)
  De Velasco MA, Uemura H.
- Journal Title
  
  Adv Urol.
  
  Volume: -
- DOI
  10.1155/2012/419348
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591781
[Journal Article] Preclinical remodeling of human prostate cancer through the PTEN/Akt pathway2012
- Author(s)
  De Velasco MA and Uemura H
- Journal Title
  
  Adv Urol
  
  Volume: 2012 Pages: 419348-419348
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591781
[Journal Article] A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system2011
- Author(s)
  Zennami K, Yoshikawa K, Kondo E, Nakamura K, Upsilonamada Y, De Velasco MA, Tanaka M, Uemura H, Shimazui T, Akaza H, Saga S, Ueda R, Honda N
- Journal Title
  
  Oncol Rep.
  
  Volume: 26 Pages: 327-333
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system2011
- Author(s)
  Zennami K, Yoshikawa K, Kondo E,, De Velasco MA, Tanaka M, Uemura H, et al.
- Journal Title
  
  Oncol Rep.
  
  Volume: 26 Pages: 327-333
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591781
[Journal Article] Basic research in kidney cancer2011
- Author(s)
  Oosterwijk E, Rathmell WK, Junker K, Brannon AR, Pouliot F, Finley DS, Mulders PF, Kirkali Z, Uemura H
- Journal Title
  
  Belldegrun A
  
  Volume: Eur Urol Pages: 622-33
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] Antitumor activity of BIBF 1120, a triple angiokinase inhibitor, and use of VEGFR2+pTyr+ peripheral blood leukocytes as a pharmacodynamic biomarker in vivo2011
- Author(s)
  Kudo K, Arao T, De Velasco MA, Hirotsugu Uemura et al
- Journal Title
  
  Clin Cancer Res
  
  Volume: 15;17(6) Pages: 1373-81
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] Kidney Cancer Working Group report.2011
- Author(s)
  Naito S., Uemura H., et al.
- Journal Title
  
  Jpn J Clin Oncol.
  
  Volume: Suppl1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-12011
- Author(s)
  Tsukamoto T, Shinohara N, Tsuchiya N, Hamamoto Y, Maruoka M, Fujimoto H, Niwakawa M, Uemura H, Usami M, Terai A, Kanayama HO, Sumiyoshi Y, Eto M, Akaza H
- Journal Title
  
  Jpn J Clin Oncol
  
  Volume: 41(1) Pages: 17-24
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] Kidney Cancer Working Group report2010
- Author(s)
  Naito S, Tomita Y, Rha SY, Uemura H, Oya M, Song HZ, Zhong LH, Wahid MI
- Journal Title
  
  Jpn J Clin Oncol
  
  Volume: 40 Suppl 1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] Molecular genetic events associated with renal cell carninoma and its implication to treatment by molecular target therapy.2010
- Author(s)
  Kishida T., Uemura H.
- Journal Title
  
  Int J Urol.
  
  Volume: 17 Pages: 198-205
- NAID
  10027257218
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination2010
- Author(s)
  Noguchi M, Mine T, Komatsu N, Suekane S, Moriya F, Matsuoka K, Yutani S, Shichijo S, Yamada A, Toh U, Kawano K, Azuma K, Uemura H, Okuno K, Matsumoto K, Yanagimoto H, Yamanaka R, Oka M, Todo S, Sasada T, Itoh K
- Journal Title
  
  Cancer Biol Ther
  
  Volume: 10(12) Pages: 1266-79
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] Assessment of immunological biomarkers in patients with advanced capcer treated by personalized peptide vaccination.2010
- Author(s)
  Noguchi M., Uemura H., et al.
- Journal Title
  
  Cancer Biol Ther.
  
  Volume: 10 Pages: 1266-1279
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390305
[Journal Article] 泌尿器腫瘍と癌抑制因子2008
- Author(s)
  植村天受
- Journal Title
  
  泌尿紀要 54
  
  Pages: 49-52
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation2008
- Author(s)
  Tomioka, A., Tanaka, M., DeVelasco, M. Anai, S., Takada, S., Kushibiki, T., Tabata, Y., Rosser, C. J., Uemura, H., Hirao, H.
- Journal Title
  
  Molecular Cancer Therapeutics 7
  
  Pages: 1864-1870
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591876
[Journal Article] Phase I/II study of individualized peptide vaccines for HLA-A2/24 positive patients with hormone-refractory prostate cancer2008
- Author(s)
  Uemura H., Minami T., Tanaka M, 他4名
- Journal Title
  
  J. Clin. Oncol. 26
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] GFP image analysis in the mouse orthotopic bladder cancer model2008
- Author(s)
  De Velasco M., Tanaka M., Uemura H, 他3名
- Journal Title
  
  Oncol Rep 20
  
  Pages: 537-542
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] Tumor vaccines in renal cell carcinoma2008
- Author(s)
  Uemura H., De Velasco M.
- Journal Title
  
  World J. Urol. 26
  
  Pages: 147-154
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] 野揮昌弘.腎細胞癌に対する免疫療法の新しい可能性2008
- Author(s)
  植村天受, 野澤昌弘
- Journal Title
  
  Urology View 6
  
  Pages: 73-77
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] GFP image analysis in the mouse orthotopic bladder cancer model2008
- Author(s)
  DeVelasco, M., Tanaka, M., Anai, S., Tomioka, A., Nishio, K., Uemura, H.
- Journal Title
  
  Oncology Report 20
  
  Pages: 537-542
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591876
[Journal Article] Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation2008
- Author(s)
  Tomioka A., Tanaka M., De Velasco M. Uemura H, 他7名
- Journal Title
  
  Mol Cancer Ther 7
  
  Pages: 1864-1870
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] 腎細胞癌に対する免疫療法の新しい可能性2008
- Author(s)
  植村天受
- Journal Title
  
  Urology View 6
  
  Pages: 73-77
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] Tumor vaccines in renal cell carcinoma2008
- Author(s)
  H. Uemura
- Journal Title
  
  World J. Urol. 26
  
  Pages: 147-154
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] Idenitification of SART3-derived peptides having the potential to induce cancer patients with HLA-A3 supertype alleles2007
- Author(s)
  Minami T., Uemura H., Harada M, 他5名
- Journal Title
  
  Cancer Immunol.Immunother 56
  
  Pages: 689-698
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] 陣癌に対するCA9ペプチドワクチン療法2007
- Author(s)
  植村天受
- Journal Title
  
  泌尿器外科 20・1
  
  Pages: 17-23
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles2007
- Author(s)
  Minami T., Matsueda S., Uemura H., et al.
- Journal Title
  
  Cancer Imuunol Immunother (In press)
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] 腎癌に対するCA9ペプチドワクチン療法2007
- Author(s)
  植村天受
- Journal Title
  
  泌尿器外科 20
  
  Pages: 17-23
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] 腎癌に対するCA9ペプチドワクチン療法2007
- Author(s)
  植村天受
- Journal Title
  
  泌尿器外科 20・1
  
  Pages: 17-23
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] Identification of SART3-derived peptides having the potential to induce cancer- reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.2007
- Author(s)
  Minami T., Matsueda S., Uemura H., et al.
- Journal Title
  
  Cancer Imuunol Immunother (In press)
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles2007
- Author(s)
  Minami T, Matsueda S, Uemura H., et al.
- Journal Title
  
  Cancer Imuunol Immunother (In press)
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] CA9 peptide vaccination therapy for renal cell carcinoma.2007
- Author(s)
  Uemura H.
- Journal Title
  
  Jap J. Urol. Surgery 20
  
  Pages: 17-23
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] STAT3 polymorphism predicts mterferon-alfa response in patients with metastatic renal cell carcinoma2007
- Author(s)
  Ito N.,Uemura H, 他18名
- Journal Title
  
  J. Clin. Oncol. 25
  
  Pages: 2785-2791
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19390419
[Journal Article] A phase l trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma.2006
- Author(s)
  Uemura H, Fujimoto K, Tanaka M, Yoshikawa M, Hirao Y, Uejima S, Yoshikawa K, Itoh K
- Journal Title
  
  Clinical Cancer Research 12
  
  Pages: 1768-1775
- Data Source
  KAKENHI-PROJECT-17591697
[Journal Article] A phase I trail of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renalcell carcinoma2006
- Author(s)
  Uemura H, Fujimoto K, Tanaka M., et al.
- Journal Title
  
  Clin Cancer Res 12・6
  
  Pages: 1768-1775
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] 腎細胞癌に対するCA9ペプチドワクチン療法2006
- Author(s)
  上島成也, 植村天受
- Journal Title
  
  Biotherapy 20
  
  Pages: 484-489
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] 「研究成果報告書概要(欧文)」より2006
- Author(s)
  Uejima S., Uemura H.
- Journal Title
  
  Biotherapy 20
  
  Pages: 484-489
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients With cytokine-refractory metastatic renal cell carcinoma.2006
- Author(s)
  Uemura H, Fujimoto K, Tanaka M, Yoshikawa M, Hirao Y, Uejima S, Yoshikawa K, Itoh K
- Journal Title
  
  Clinical Cancer Research 12
  
  Pages: 1768-1775
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591697
[Journal Article] Fujimoto K., Tanaka M., et al., A phase I trail of vaccination of CA9-derived peptides for HLA-A24- positive patients with cytokine-refractory metastatic renal cell carcinoma.2006
- Author(s)
  Uemura H.
- Journal Title
  
  Clin Cancer Res 12
  
  Pages: 1768-1775
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma2006
- Author(s)
  Uemura H., Fujimoto K., et al.
- Journal Title
  
  Clinical Cancer Research 12・6(in press)
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] A phase I trail of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma2006
- Author(s)
  Uemura H., Fujimoto K., Tanaka M., et al.
- Journal Title
  
  Clin Cancer Res 12・6
  
  Pages: 1768-1775
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] ワクチン療法の理論と実際2006
- Author(s)
  植村天受
- Journal Title
  
  Urology View 4・1
  
  Pages: 83-89
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma.2005
- Author(s)
  Uemura H, Fujimoto K, Tanaka M, Yoshikawa M, Hirao Y, Uejima S, Yoshikawa K, Itoh K.
- Journal Title
  
  Clinical Cancer Research 12
  
  Pages: 1768-1775
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591697
[Journal Article] 泌尿器科癌に対するペプチドワクチン療法2005
- Author(s)
  植村天受
- Journal Title
  
  Urology View 3・3
  
  Pages: 102-107
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] 腎細胞癌のワクチン療法2005
- Author(s)
  植村天受
- Journal Title
  
  Annual Review 2005 腎臓
  
  Pages: 221-225
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] 泌尿器科癌に対するペプチドワクチン療法2005
- Author(s)
  植村天受
- Journal Title
  
  Urology View 13・3
  
  Pages: 102-107
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] 腎細胞癌のワクチン療法2005
- Author(s)
  植村天受
- Journal Title
  
  Annual Review
  
  Pages: 221-225
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] Vaccination therapy for renal cell carcinoma.2005
- Author(s)
  Uemura H.
- Journal Title
  
  Annual Review
  
  Pages: 221-225
- NAID
  40017065250
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] Peptide vaccination therapy for urologic cancers.2005
- Author(s)
  Uemura H.
- Journal Title
  
  Urology View 13
  
  Pages: 102-107
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-16390468
[Journal Article] 腎細胞癌治療の現状と課題:腎細胞癌におけるITC(isolated tumor cell)の意義2004
- Author(s)
  植村天受
- Journal Title
  
  泌尿器外科 17
  
  Pages: 661-665
- Data Source
  KAKENHI-PROJECT-16390468
[Patent] HLA-A24分子に結合でき、かつ細胞性免疫に認識されるHIF-1α由来ペプチド、及びそれを含む腎細胞癌ワクチン2016
- Inventor(s)
  植村天受、南高文
- Industrial Property Rights Holder
  植村天受、南高文
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2016-209180
- Filing Date
  2016-10-26
- Data Source
  KAKENHI-PROJECT-16H05466
[Patent] 細胞性免疫に認識されるペプチド、及びそれを利用した医薬薬剤2014
- Inventor(s)
  植村天受
- Industrial Property Rights Holder
  植村天受
- Industrial Property Rights Type
  特許
- Filing Date
  2014-09-17
- Data Source
  KAKENHI-PROJECT-25293336
[Patent] 腎細胞がんの予防又は治療に好適なペプチド、核酸分子、及びベクター、並びにそられの利用2014
- Inventor(s)
  植村天受
- Industrial Property Rights Holder
  植村天受
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2014-007671
- Filing Date
  2014-01-20
- Data Source
  KAKENHI-PROJECT-25293336
[Patent] HLA-A3スーパータイプアレル陽性前立腺癌患者に対する癌ワクチン療法に有用なEZH2由来ペプチド2014
- Inventor(s)
  植村　天受
- Industrial Property Rights Holder
  植村　天受
- Industrial Property Rights Type
  特許
- Filing Date
  2014-09-26
- Data Source
  KAKENHI-PROJECT-24592416
[Presentation] Pim キナーゼ阻害薬は去勢抵抗性前立腺癌マウスモデルにおいて腫瘍増殖を抑制し生存期間を延長する2019
- Author(s)
  倉　由吏恵、清水　信貴、森　康範、南　高文、野澤　昌弘、吉村一宏、西尾和人、デベラスコ・マルコ、植村　天受
- Organizer
  第２３回　日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] リアルタイムPCRを用いた腫瘍免疫プロファイルと免疫反応性の評価んについて2019
- Author(s)
  野澤　昌弘、デベラスコ・マルコ、倉　由吏恵、坂井　和子、吉川　和宏、西尾　和人、植村　天受
- Organizer
  第78回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] 前立腺癌における分子標的薬と次世代アンチセンスオリゴの併用効果について2019
- Author(s)
  デベラスコ・マルコ、倉由吏恵、坂井和子、藤田至彦、西尾和人、植村天受
- Organizer
  第23回日本がん分子標的治療学会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] A real-time PCR-based approach to quantitatively assess tumor immune profiles and immune responses2019
- Author(s)
  デベラスコ・マルコ、倉　由吏恵、佐古紀子、安藤直美、坂井和子、森　康範、Barry R.Davies、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
- Organizer
  AACR
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] Dietary isoflavone decreases prostate cancer progression and improves survival in conditional Pten/Trp53-deficient mice.2019
- Author(s)
  asunori Mori, Marco A. De Velasco, Yurie Kura, Eri Banno, Naomi Anod, Noriko Sako, Masahiro Nozawa, Kazuhiro Yoshimura, Kazuko Sakai, Kazuhiro Yoshikawa, Kazuto Nishio, Hirotsugu Uemura
- Organizer
  AACR2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] 前立腺癌における遺伝子改変マウスモデルについて2019
- Author(s)
  植村天受、倉由吏恵、清水信貴、森康範、南高文、野澤昌弘、西尾和人、デベラスコ・マルコ
- Organizer
  第107日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] 前立腺癌における遺伝子改変マウスモデル新たな発見と発展のツールとして2019
- Author(s)
  倉　由吏恵、デベラスコ・マルコ、植村天受
- Organizer
  第107日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] A real-time PCR-based approach to quantitatively assess tumor immune profiles and immune responses.2019
- Author(s)
  Marco A. De Velasco, Yurie Kura, Naomi Anod, Noriko Sako, Kazuhiro Yoshimura, Kazuko Sakai, Yasunori Mori, Barry R. Davies, Masahiro Nozawa, Kazuhiro Yoshikawa, Kazuto Nishio, Hirotsugu Uemura
- Organizer
  AACR2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] Profiling the tumor immune milieu to assess and predict immune responses2019
- Author(s)
  デベラスコ・マルコ、倉由吏恵、森康範、大関孝之、坂井和子、野澤昌弘、吉村一弘、吉川和宏、西尾和人、植村天受
- Organizer
  第78日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] アンドロゲン受溶体標的治療は前立腺癌の腫瘍微小免疫環境えお変化させる2019
- Author(s)
  植村　天受、デベラスコ・マルコ
- Organizer
  第78回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] Apalutamide reworks the immune composition of prostate tumors.2019
- Author(s)
  Marco A. De Velasco, Yurie Kura, Naomi Anod, Noriko Sako, Masahiro Nozawa, Kazuhiro Yoshimura, Kazuko Sakai, Kazuhiro Yoshikawa, Kazuto Nishio, Hirotsugu Uemura
- Organizer
  AACR2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] Apalutamide reworks the immune composition of prostate tumors2019
- Author(s)
  デベラスコ・マルコ、倉　由吏恵、安藤直美、佐古紀子、野澤昌弘、吉村一宏、坂井和子、吉川和宏、西尾和人、植村天受
- Organizer
  AACR
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] 前立腺癌における遺伝子改変マウスモデル：ヒトからマウスへ－マウスからヒトへ2018
- Author(s)
  植村　天受（近大）、デベラスコ・マルコ（近大、近大ゲノム）
- Organizer
  第７７回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] Ｐｔｅｎノックアウトマウス前立腺癌モデルにおけるマルチキナ－ゼ阻害薬TAS/115の有効性についての検討2018
- Author(s)
  野澤　昌弘（近大）、デベラスコ・マルコ（近大、近大ゲノム）、倉　由吏恵、清水　信貴、森　康範、吉村　一宏（近大）、坂井　和子（近大ゲノム）、吉川　和宏（愛知医大）、西尾　和人（近大ゲノム）、植村　天受（近大）
- Organizer
  第７７回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] Pimキナ-ゼ阻害薬は去勢抵抗性マウス前立腺癌モデルにおいて腫瘍増殖を抑制し生存期間を延長する2018
- Author(s)
  倉　由吏恵（近大）、デベラスコ・マルコ（近大、近大ゲノム）、森　康範、清水　信貴、大關　孝之（近大）、坂井　和子（近大ゲノム）、野澤　昌弘、吉村　一宏（近大）、吉川　和宏（愛知医大）、西尾　和人（近大ゲノム）、植村　天受（近大）
- Organizer
  第７７回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] ptenノックアウトマウス前立腺癌モデルを用いたアビラテロンによる抗腫瘍免疫効果に関する検討2018
- Author(s)
  清水　信貴（近大）、デベラスコ・マルコ（近大、近大ゲノム）、倉　由吏恵、大關　孝之、森　康範、野澤　昌弘、吉村　一宏、（近大）、坂井　和子（近大ゲノム）、吉川　和宏（愛知医大）、西尾　和人（近大ゲノム）、植村　天受（近大）
- Organizer
  第７７回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] 免疫療法開発における遺伝子改変マウス前立腺癌モデルの有用性について2018
- Author(s)
  デベラスコ・マルコ（近大、近大ゲノム）、倉　由吏恵、森　康範、清水　信貴、大關　孝之（近大）、坂井　和子（近大ゲノム）、野澤　昌弘、吉村　一宏（近大）、吉川　和宏（愛知医大）、西尾　和人（近大ゲノム）、植村　天受（近大）
- Organizer
  第７７回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] 前立腺癌患者の予後不良に関わる遺伝子絆の同定2018
- Author(s)
  橋本　士（近大）、デベラスコ・マルコ（近大、近大ゲノム）、倉　由吏恵（近大）、坂井　和子（近大ゲノム）、清水　信貴（近大）、森　康範、野澤　昌弘、吉村　一宏、（近大）、吉川　和宏（愛知医大）、西尾　和人（近大ゲノム）、植村　天受（近大）
- Organizer
  第７７回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] 遺伝子改変Pten ノックアウトマウス前立腺癌モデルにおけるApalutamideの有効性についての検討2018
- Author(s)
  森　康範（近大）、デベラスコ・マルコ（近大、近大ゲノム）、倉　由吏恵（近大）、大關　孝之、清水　信貴、野澤　昌弘、吉村　一宏、（近大）、坂井　和子（近大ゲノム）、吉川　和宏（愛知医大）、西尾　和人（近大ゲノム）、植村　天受（近大）
- Organizer
  第７７回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] ヒト前立腺癌におけるSTAT3について2017
- Author(s)
  森　康範、デベラスコ　マルコ、畑中祐二、倉　由吏恵、杉本公一、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] Therapeutic potential of combination therapy using a next-generation antisense oligonucleotide targeting the androgen receptor and AKT inhibition with AZD5363 in genetically engineered mouse models of prostate cancer2017
- Author(s)
  デベラスコ　マルコ、倉由吏恵、安藤直美、杉本公一、坂井和子、Barry R. Davies、Youngsoo Kim、A. Robert Macleod、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
- Organizer
  AACR
- Place of Presentation
  ワシントンDC, USA
- Year and Date
  2017-04-02
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] PD-L1 blockade in preclinical models of PTEN-deficient prostate cancer2017
- Author(s)
  デベラスコ　マルコ、倉由吏恵、安藤直美、佐古紀子、Barry R. Devies、杉本公一、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
- Organizer
  AACR
- Place of Presentation
  ワシントンDC, USA
- Year and Date
  2017-04-02
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] 遺伝子改変前立腺癌マウスモデルにおけるPD-L1免疫チェックポイント阻害薬について2017
- Author(s)
  清水信貴、デベラスコマルコ、倉　由吏恵、坂井和子、杉本公一、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] AKTおよびPimキナーゼをターゲットにした治療戦略はPTEN欠出前立腺癌前臨床動物モデルにおいて治療効果改善を示す2017
- Author(s)
  倉　由吏恵、デベラスコ　マルコ、杉本公一、坂井和子、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] 遺伝子改変マウス前立腺癌モデルを用いた新規化合物の包括的前臨床評価について2017
- Author(s)
  植村天受、倉　由吏恵、杉本公一、森　康範、野澤昌弘、吉村一宏、吉川和宏、西尾和人、デベラスコ　マルコ
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] Co-targeting of AKT and Pim kinases in mouse PTEN-deficient prostate cance2017
- Author(s)
  倉由吏恵、デベラスコ　マルコ、安藤直美、佐古紀子、杉本公一、坂井和子、Barry R. Davies、Dennis Huszay、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
- Organizer
  AACR
- Place of Presentation
  ワシントンDC, USA
- Year and Date
  2017-04-02
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] ＰＴＥＮノックアウト前立腺癌マウスモデルにおける腫瘍免疫の包括的分析2017
- Author(s)
  デベラスコマルコ、倉　由吏恵、坂井和子、杉本公一、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K11165
[Presentation] PTENノックアウトマウス前立腺癌におけて選択的スプライシング2016
- Author(s)
  デベラスコ　マルコ、倉由吏恵、坂井和子、藤田至彦、冨樫庸介、寺嶋雅人、吉川和宏、西尾和人、植村天受
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜、神奈川県横浜市
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] PTENノックアウトマウス前立腺癌におけるノンコーディングRNAの2016
- Author(s)
  倉由吏恵、デベラスコ　マルコ、坂井和子、藤田至彦、冨樫庸介、寺嶋雅人、吉川和宏、西尾和人、植村天受
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜、神奈川県横浜市
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] PTENノックアウト前立腺癌マウスモデルにおけるJAK1/2阻害によ2016
- Author(s)
  植村天受、倉由吏恵、森康範、畑中祐二、沖貴士、杉本公一、吉村一宏、野澤昌弘、吉川和宏、西尾和人、デベラスコ　マルコ
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜、神奈川県横浜市
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] 遺伝子改変と前立腺癌マウスモデルにおける高脂肪食摂取による腫瘍増殖2016
- Author(s)
  森康範、デベラスコ　マルコ、倉由吏恵、畑中祐二、沖貴士、杉本公一、吉村一宏、野澤昌弘、吉川和宏、西尾和人、植村天受
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜、神奈川県横浜市
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] PTEN/p53ダブルノックアウト前立腺癌マウスモデルにおけるクロ2016
- Author(s)
  杉本公一、デベラスコ　マルコ、倉由吏恵、森康範、畑中祐二、沖貴士、吉村一宏、野澤昌弘、吉川和宏、西尾和人、植村天受
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜、神奈川県横浜市
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] Chloroquine demonstrates limited effectiveness in an autochthonous preclinical model of prostate cancer2015
- Author(s)
  Kura Y., De Velasco MA., Uemura H. et al.
- Organizer
  AACR
- Place of Presentation
  フィラデルフィア, アメリカ
- Year and Date
  2015-04-20
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] Effects of long-term chloroquine chemotherapy in a preclinical model of PTEN-deficier2015
- Author(s)
  Yoshikawa K., De Velasco M., Uemura H. et al
- Organizer
  AACR
- Place of Presentation
  フィラデルフィア, アメリカ
- Year and Date
  2015-04-20
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26670707
[Presentation] 去勢抵抗性前立腺癌に対する免疫療法2015
- Author(s)
  吉村一宏、植村天受　ほか
- Organizer
  第65回　日本泌尿器科学会中部総会
- Place of Presentation
  長良川国際会議場、岐阜都ホテル
- Year and Date
  2015-10-23
- Data Source
  KAKENHI-PROJECT-25293336
[Presentation] Preclinical effects of dual AKT/MAPK inhibition in PTEN-deficient prostate cancer2015
- Author(s)
  De Velasco MA., Yamamot Y., Uemura H, et al.
- Organizer
  AACR
- Place of Presentation
  フィラデルフィア, アメリカ
- Year and Date
  2015-04-20
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] マウス前立腺癌モデルを用いたAKT阻害薬 AZD 5356の抗腫瘍効果2015
- Author(s)
  Uemura H., Kura Y., De Velasco MA. et al.,
- Organizer
  第74回　日本癌学会学術総会
- Place of Presentation
  名古屋コングレスセンター
- Year and Date
  2015-10-09
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] マウス前立腺癌モデルを用いたAKT阻害薬 AZD 5356の抗腫瘍効果2015
- Author(s)
  Uemura H., Kura Y., Shimizu N. et al.
- Organizer
  第74回日本癌学会学術総会
- Place of Presentation
  名古屋コングレスセンター
- Year and Date
  2015-10-09
- Data Source
  KAKENHI-PROJECT-26670707
[Presentation] Effects of long-term chloroquine chemotherapy in a preclinical model of PTEN-deficier2015
- Author(s)
  Yoshikawa K., De Velasco MA.,　Uemura H. et al
- Organizer
  AACR
- Place of Presentation
  フィラデルフィア, アメリカ
- Year and Date
  2015-04-20
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] Chloroquine demonstrates limited effectiveness in an autochthonous preclinical model of prostate cancer2015
- Author(s)
  Kura Y., De Velasco M., Uemura H. et al.
- Organizer
  AACR
- Place of Presentation
  フィラデルフィア, アメリカ
- Year and Date
  2015-04-20
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26670707
[Presentation] Clinical role of MHC-class I peptide vaccines for metastatic renal cell carcinoma2013
- Author(s)
  T Minami, T Minami, N Shimizu, Y Yamamoto, M De Velasco, T Hayashi, M Nozawa, K Yoshimura, T Ishii, H Uemura
- Organizer
  28th Annual EAU Congress
- Place of Presentation
  Milan
- Year and Date
  2013-03-18
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] Leptin contributes to prostate cancer progression.2013
- Author(s)
  Marco A De Velasco, Yutaka Yamamoto, Yuji Hatanaka, Yurie Kura, Naomi Ando, Emiko Fukushima, Masahiro Noazawa, Nobutaka Shimizu, Kazuhiro Yoshimura, Kazuhiro Yoshikawa, Kazuto Noshio, Hirotsugu Uemura.
- Organizer
  AACR Annual Meeting 2013
- Place of Presentation
  Washington DC
- Year and Date
  2013-04-09
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] Autophagy is required for prostate cancer progression2013
- Author(s)
  Marco A De Velasco, Yurie Kura, Naomi Ando, Emiko Fukushima, Yuji Hatanaka, Yutaka Yamamoto, Nobutaka Shimizu, Kazuhiro Yoshimura, Masahiro Nozawa, Kazuhiro Yoshikawa, Kazuto Nishio, Hirotsugu Uemura
- Organizer
  AACR Annual Meeting 2013
- Place of Presentation
  Washington DC
- Year and Date
  2013-04-07
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] A ole for lumican as a biomarker of disease progression in human prostate adenocarcinoma2013
- Author(s)
  Marco A De Velasco, Hirotsugu Uemura, et al
- Organizer
  AACR Annual Meeting 2013
- Place of Presentation
  Washington DC
- Year and Date
  2013-04-07
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] Interleukin-6 (IL-6) as a therapeutic target in prostate cancer.2013
- Author(s)
  Yurie Kura, Marco A De Velasco, Yasuyuki Kobayashi, Naomi Ando, Emiko Fukushima, Yutaka Yamamoto, Yuji Hatanaka, Nobutaka Shimizu, Kazuhiro Yoshimura, Masahiro Nozawa, Kazuhiro Yoshikawa, Kazuto Nishio, Hirotsugu Uemura
- Organizer
  AACR Annual Meeting 2013
- Place of Presentation
  Washington DC
- Year and Date
  2013-04-08
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] Preclinical responses of the MEK inhibitor AZD6244 in a genetically modified mouse model of prostate cancer2013
- Author(s)
  Hirotsugu Uemura, Marco A De Velasco, et al
- Organizer
  AACR Annual Meeting 2013
- Place of Presentation
  Washington DC
- Year and Date
  2013-04-07
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] Therapeutic potential of JAK/STAT signal inhibition in prostate cancer by the JAK inhibitor AZD14802013
- Author(s)
  Marco A. De Velasco, Hirotsugu Uemura, et al
- Organizer
  AACR Annual Meeting 2013
- Place of Presentation
  Washington DC
- Year and Date
  2013-04-07
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] Role of Stat3 transcriptional activation in a preclinical mouse model of prostate cancer and potential as a therapeutic target2012
- Author(s)
  De Velasco MA, Uemura H, et al.
- Organizer
  Cancer Res
- Year and Date
  2012-04-15
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] ヒト前立腺がんにおけるルミカンの発現について2012
- Author(s)
  吉村一宏、デベラスコマルコ、植村天受、他
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Year and Date
  2012-09-20
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] 転移性腎がんに対するMHC クラスI ペプチドワクチン療法の役割2012
- Author(s)
  植村天受、吉村一宏、南高文、デベラスコマルコ
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Year and Date
  2012-09-19
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] 前立腺特異的PTENノックアウトマウスにおけるSTAT3 の転写活性に関する検討2012
- Author(s)
  小林泰之、デベラスコマルコ、植村天受、他
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Year and Date
  2012-09-21
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] Diet-induced leptin contributes to prostate cancer progression2012
- Author(s)
  Marco A De Velasco, Hirotsugu Uemura, et al.
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Year and Date
  2012-09-21
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] Enhanced anti-tumor effects using a combinatorial targeted treatment strategy in a preclinical model of prostate cancer2012
- Author(s)
  De Velasco MA, Uemura H, et al
- Organizer
  Cancer Res
- Year and Date
  2012-04-15
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] ヒト前立腺癌の進展におけるHOXA10 の発現異常について2012
- Author(s)
  畑中祐二、デベラスコマルコ、植村天受、他
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Year and Date
  2012-09-21
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] HLA-A24 陽性腎細胞癌患者におけるcancer-reactive CTLs を誘導し得るEpoR 抗原由来ペプチドの同定2012
- Author(s)
  南高文、南知子、大関孝之、デベラスコマルコ、清水信貴、山本豊、辻秀憲、野澤昌弘、吉村一宏、植村天受
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Year and Date
  2012-09-19
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] The Clinical role of peptide vaccines for castration-resistant prostate cancer2012
- Author(s)
  Takafumi Minami, Takahiro Kimura, Masahiro Nozawa, Kazuhiro Yoshimura, Toru Nakagawa, Akira Yamada, Kyogo Ito, Hiroyuki Fujimoto, Shi Egawa, Hirotsugu Uemura
- Organizer
  The 10th Annual Meeting of Japanese Society of Medical Oncology
- Place of Presentation
  Osaka
- Year and Date
  2012-07-18
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] 前立腺癌マウスモデルに対する分子標的治療薬の抗腫瘍効果の検討2012
- Author(s)
  山本豊、デベラスコマルコ、倉由吏恵、畑中祐二、吉村一宏、清水信貴、野澤昌弘、吉川和宏、西尾和人、植村天受
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Year and Date
  2012-09-21
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] A phase I trial of VEGFR1 peptide vaccines for patients with metastatic renal cell carcinoma2011
- Author(s)
  植村天受
- Organizer
  Annual Meeting of American Urological Association
- Place of Presentation
  ワシントン
- Year and Date
  2011-05-17
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] Pre-clinical chemopreventive efficacy of chlormadinone acetate against prostate cancer2010
- Author(s)
  Koike H., De Velasco M., Uemura H., et al
- Organizer
  69th Annual Meeting of the Japanese Cancer Association
- Place of Presentation
  大阪市
- Year and Date
  2010-09-23
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] Anti-tumor effects of everolimus and chlormadinone acetate against prostate cancer in a pre-clinical mouse model2010
- Author(s)
  De Velasaco M., Uemura H., et al.
- Organizer
  69th Annual Meeting of the Japanese Cancer Association
- Place of Presentation
  大阪市
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] The prostate-specific PTEN conditional knockout mouse as a model for human prostate cancer2010
- Author(s)
  De Velasaco M., Uemura H., et al.
- Organizer
  69th Annual Meeting of the Japanese Cancer Association
- Place of Presentation
  大阪市
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] Uemura H. Insights into treatment efficacy in Japanese metastatic renal cell carcinoma patients2009
- Author(s)
  Uemura H.
- Organizer
  The 24^<th> Annual Meeting of European Association of Urology
- Place of Presentation
  Stockholm Sweden
- Year and Date
  2009-03-17
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] A phase-II study of CA9 peptide vaccines in combination with mterferon-alpha in advaced renal cell carcinoma. American Sociaty for Clinical Oncology2009
- Author(s)
  Uemura H.
- Organizer
  Genitourinary Cancer Symposium
- Place of Presentation
  Orland USA
- Year and Date
  2009-02-27
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] Phase I/II study of individualized peptide vaccines for HLA-A2/A24 positive patients with hormone-refractory prostate cancer2008
- Author(s)
  Uemura H.
- Organizer
  The 44^<th> Annual Meeting of American Society for Clinical Oncology
- Place of Presentation
  Chicago USA
- Year and Date
  2008-05-31
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] A phase II study of the efficacy and safety of sunitinib in Japanese patients with metastatic renal cell carcinoma (mRCC)2008
- Author(s)
  H. Uemura
- Organizer
  24^<th> URS
- Place of Presentation
  オランダ、アムステルダム
- Year and Date
  2008-09-19
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] A phase II study of the efficacy and safety of sunitinib in Japanese patients with metastatic renal cell carcinoma (mRCC)2008
- Author(s)
  Uemura H.
- Organizer
  The 24^<th> Annual Meeting of Urological Research Society
- Place of Presentation
  Amsterdam The Netherlands
- Year and Date
  2008-09-19
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] 難治性腎細胞癌に対するペプチドワクチン療法2008
- Author(s)
  植村天受
- Organizer
  第21回日本バイオセラピィ学術集会総会
- Place of Presentation
  東京
- Year and Date
  2008-11-18
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] 難治性腎細胞癌に対するペプチドワクチン療法2008
- Author(s)
  植村天受
- Organizer
  第21回日本バイオセラピィ学会学術集会総会
- Place of Presentation
  東京
- Year and Date
  2008-11-18
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] 転移性腎細胞癌に対する新規分子標的薬による治療経験2008
- Author(s)
  植村天受
- Organizer
  第46回日本癌治療学会総会
- Place of Presentation
  名古屋市
- Year and Date
  2008-10-31
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] 難治性腎細胞癌に対する分子標的治療薬の使用経験2007
- Author(s)
  植村天受
- Organizer
  第45回日本癌治療学会総会
- Place of Presentation
  京都市
- Year and Date
  2007-10-24
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] Phase I/II study of CA9 peptide vaccination with interferon-alpha in cytokine refractory renal cancer patients2007
- Author(s)
  Uemura H
- Organizer
  第66回日本癌学会
- Place of Presentation
  横浜市
- Year and Date
  2007-10-04
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] Phase-I/II trial of CA9 peptide vaccination in combination with mterferon-alpha in HLA-A24 positive patients with cytokme refractory renal cell carcinoma2007
- Author(s)
  Uemura H.
- Organizer
  Annual Meeting of American Urological Association
- Place of Presentation
  Anaheim USA
- Year and Date
  2007-05-20
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] A phase I trial of vaccination of personalized peptides for HLA-A2/A24 positive patients with hormone-refractory prostate cancer2007
- Author(s)
  Uemura H.
- Organizer
  Annual Meeting of American Urological Association
- Place of Presentation
  Anaheim USA
- Year and Date
  2007-05-20
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] CA9 peptide vaccination in combination with mterferon-alpha in HLA-A24 positive patients with cytokme refractory renal cell carcinoma2007
- Author(s)
  Uemura H.
- Organizer
  The 24^<th> Annual Meeting of Urological Research Society
- Place of Presentation
  CA USA
- Year and Date
  2007-10-26
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] A Phase I trial of vaccination of personalized peptides for HLA-A2/A24positive patients with hormone-refractory prostate cancer2007
- Author(s)
  Uemura H
- Organizer
  アメリカ泌尿器科学会
- Place of Presentation
  アナハイム、USA
- Year and Date
  2007-05-20
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] サイトカイン療法抵抗性腎癌に対する新しい治療戦略2007
- Author(s)
  植村天受
- Organizer
  第37回日本腎臓学会西部学術大会
- Place of Presentation
  福井市
- Year and Date
  2007-10-20
- Data Source
  KAKENHI-PROJECT-19390419
[Presentation] Development of a lethal genetically engineered mouse model of prostate cancer for surivival studies and end-stage cancer
- Author(s)
  植村天受、倉由吏恵、畑中祐二、山本　豊、清水信貴、吉村一宏、野澤昌弘、吉川和宏、西尾和人、デベラスコ　マルコ
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜市（パシフィコ横浜）
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] A role for iumican as a biomarker of disease progression in human prostate adenocarcinoma
- Author(s)
  De Verasco M., Hatanaka Y., Uemura H. et.al.
- Organizer
  AACR Annual Meeting 2013
- Place of Presentation
  Washington, DC, USA
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] 前立腺癌におけるオートファジーの生物学的意義
- Author(s)
  デベラスコ　マルコ、倉由吏恵、安藤直美、福島恵美子、畑中祐二、山本　豊、清水信貴、吉村一宏、野澤昌弘、吉川和宏、西尾和人、植村天受
- Organizer
  第102回日本泌尿器科学会総会
- Place of Presentation
  神戸市（神戸国際会議場・神戸国際展示場・神戸ポートピアホテル）
- Year and Date
  2014-04-24 – 2014-04-27
- Data Source
  KAKENHI-PROJECT-26670707
[Presentation] Functional evaluation of synchronous inactivation of PTEN and P53 in a murine model of prostate cancer.
- Author(s)
  H. Uemura, Y. Kura, N. Ando, E. Fukushima, Y. Hatanaka, Y. Yamamoto, N. Shimizu, K. Yoshimura, M. Nozawa, K. Yoshikawa, K. Nishio and M.A. De Velasco
- Organizer
  AACR
- Place of Presentation
  San Diego
- Year and Date
  2014-04-05 – 2014-04-09
- Data Source
  KAKENHI-PROJECT-26462433
[Presentation] Autophagy in prostate tumorigenes and its clinical implications
- Author(s)
  デベラスコ　マルコ、倉由吏恵、畑中祐二、山本　豊、清水信貴、吉村一宏、野澤昌弘、吉川和宏、西尾和人、植村天受
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜市（パシフィコ横浜）
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-26670707
[Presentation] Leptin contributes to prostate cancer
- Author(s)
  De Velasco M., Yamamot Y., Uemura H. et.al.
- Organizer
  AACR Annual Meeting 2013
- Place of Presentation
  Washington, DC, USA
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] Interleukin-6(IL-6) as a therapeutic target in prostate cancer
- Author(s)
  Kura Y., De Velasco M., Uemura H. et.al.
- Organizer
  AACR Annual Meeting 2013
- Place of Presentation
  Washington, DC, USA
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] Autophagy is required for prostate cancer progression
- Author(s)
  De Velasco M., Y. Kura, Uemura H. et.al.
- Organizer
  AACR Annual Meeting 2013
- Place of Presentation
  Washington, DC, USA
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] HLA-A24陽性腎細胞癌患者におけるcancer-rective CTLsを誘導し得るEpoR抗原由来ペプチドの同定
- Author(s)
  南　高文、植村天受ほか
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  ロイトン札幌（札幌市）
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] Preclinical responses of the MEK inhibitor AZD6244 in an genetically modified mouse model of prostate cancer
- Author(s)
  Uemura H., Kura Y., De Velasco M. et.al.
- Organizer
  AACR Annual Meeting 2013
- Place of Presentation
  Washington, DC, USA
- Data Source
  KAKENHI-PROJECT-22591781
[Presentation] 転移性腎癌に対するMHCクラスIペプチドワクチン療法の役割
- Author(s)
  植村天受、吉村一宏ほか
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  ロイトン札幌（札幌市）
- Data Source
  KAKENHI-PROJECT-22390305
[Presentation] The role of autophagy in prostate tumorigenesis and its therapeutic implications
- Author(s)
  M.A. De Velasco, Y. Kura, N. Ando, E. Fukushima, Y. Hatanaka, Y. Yamamoto, N. Shimizu, K. Yoshimura, M. Nozawa, K. Yoshikawa, K. Nishio and H. Uemura
- Organizer
  AACR
- Place of Presentation
  San Diego
- Year and Date
  2014-04-05 – 2014-04-09
- Data Source
  KAKENHI-PROJECT-26670707

1. YOSHIKAWA Kazuhiro (60109759)

# of Collaborated Projects: 11 results

# of Collaborated Products: 3 results
2. DEVELASCO Marco (20449838)

# of Collaborated Projects: 10 results

# of Collaborated Products: 78 results
3. HIRAO Yoshihiko (00133207)

# of Collaborated Projects: 10 results

# of Collaborated Products: 3 results
4. MINAMI Takafumi (70340809)

# of Collaborated Projects: 6 results

# of Collaborated Products: 15 results
5. TANAKA Motoyoshi (30347562)

# of Collaborated Projects: 5 results

# of Collaborated Products: 10 results
6. CHO Masaki (90285362)

# of Collaborated Projects: 5 results

# of Collaborated Products: 0 results
7. HARADA Mamoru (50260716)

# of Collaborated Projects: 4 results

# of Collaborated Products: 6 results
8. YOSHIMURA Kazuhiro (20283757)

# of Collaborated Projects: 3 results

# of Collaborated Products: 14 results
9. NOZAWA Masahiro (00441080)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
10. UEJIMA Shigeya (60213336)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
11. SHIMADA Keiji (90336850)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
12. OKAJIMA Eigoro (50075115)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
13. FUJIMOTO Kiyohide (50264867)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
14. KONISHI Noboru (20145832)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
15. OZONO Seiichiro (00183228)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. TSUNODA Takuya (30275359)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. SAGA Shinsuke (40144141)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. TANAKA Masahiro (00382292)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
19. 百瀬均 (20210106)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. 仲川嘉紀 (60281276)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
21. 岡島英二郎 (70326346)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
22. 坂本信一 (70422235)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
23. 西尾和人 (10208134)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
24. 金田篤志 (10313024)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
25. 今村有佑 (10568629)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
26. 坂井和子 (20580559)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
27. 川上英良 (30725338)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
28. 落谷孝広 (60192530)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
29. 安西尚彦 (70276054)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
30. 原嶋奈々江

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
31. 松原昭郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
32. 太田明伸

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

UEMURA Hirotsugu 植村 天受

植村 大受 ウエムラ ヒロツグ

Research Projects

Research Products

Co-Researchers

Establishment of aminoacid transporter directed prostate cancer therapy based on the liquid biopsyOngoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

前立腺癌における腫瘍微小免疫環境の変化に関する基礎的研究Ongoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

腎細胞癌に対するマルチペプチド癌ワクチンの開発、複合免疫療法としての有用性の検討Principal InvestigatorOngoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of the HLA-A2 restricted multi-peptides vaccine for renal cell carcinoma.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Functional analysis of autophagy in PTEN/Atg7 double knockout mouse prostate cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of multi-peptide tumor vaccine for renal cell carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of tailor made peptide vaccines for renal cell carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of tailor-madepeptide vaccines for renal eell carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

UEMURA Hirotsugu 植村天受

植村大受ウエムラヒロツグ